| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other comprehensive loss | 177 | -132 | -151 | 639 |
| Comprehensive loss | -9,639 | -11,918 | -8,341 | -5,699 |
| Earnings per share, basic | -0.24 | -0.29 | -0.2 | -0.16 |
| Earnings per share, diluted, total | -0.24 | -0.29 | -0.2 | -0.16 |
| Weighted average number of shares outstanding, basic, total | 40,965,219 | 40,743,786 | 40,509,646 | 39,788,621 |
| Weighted average number of shares outstanding, diluted | 40,965,219 | 40,743,786 | 40,509,646 | 39,788,621 |
RxSight, Inc. (RXST)
RxSight, Inc. (RXST)